Biomarker development for PD-(L)1 axis inhibition: a consensus view from the SITC Biomarkers Committee.
- DOI
- 10.1136/jitc-2024-009427
- Published
- 2024 Jul 20
- Container
- Journal for immunotherapy of cancer
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1136/jitc-2024-009427,
title = {Biomarker development for PD-(L)1 axis inhibition: a consensus view from the SITC Biomarkers Committee.},
author = {Monette A and Warren S and Barrett JC and Garnett-Benson C and Schalper KA and Taube JM and Topp B and Snyder A},
year = {2024},
journal = {Journal for immunotherapy of cancer},
doi = {10.1136/jitc-2024-009427},
url = {https://doi.org/10.1136/jitc-2024-009427}
}RIS
TY - JOUR TI - Biomarker development for PD-(L)1 axis inhibition: a consensus view from the SITC Biomarkers Committee. AU - Monette A AU - Warren S AU - Barrett JC AU - Garnett-Benson C AU - Schalper KA AU - Taube JM AU - Topp B AU - Snyder A PY - 2024 JO - Journal for immunotherapy of cancer DO - 10.1136/jitc-2024-009427 UR - https://doi.org/10.1136/jitc-2024-009427 ER -
APA
A, M., S, W., JC, B., C, G., KA, S., JM, T., B, T., & A, S. (2024). Biomarker development for PD-(L)1 axis inhibition: a consensus view from the SITC Biomarkers Committee.. Journal for immunotherapy of cancer. https://doi.org/10.1136/jitc-2024-009427
Source records
- pubmed · retrieved 2026-09-26T02:39:46.039Z